HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 79 filers reported holding HARVARD BIOSCIENCE INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,459,725 | +0.1% | 339,471 | +27.8% | 0.00% | 0.0% |
Q2 2023 | $1,458,418 | +260331.8% | 265,650 | +99.2% | 0.00% | – |
Q1 2023 | $560 | +23.1% | 133,375 | -18.8% | 0.00% | – |
Q4 2022 | $455 | -99.9% | 164,230 | -20.2% | 0.00% | – |
Q3 2022 | $527,000 | -62.5% | 205,707 | -47.4% | 0.00% | -100.0% |
Q2 2022 | $1,407,000 | +196.2% | 390,966 | +410.7% | 0.00% | – |
Q1 2022 | $475,000 | -27.8% | 76,553 | -18.0% | 0.00% | – |
Q4 2021 | $658,000 | -33.3% | 93,348 | -33.9% | 0.00% | -100.0% |
Q3 2021 | $986,000 | -18.7% | 141,251 | -3.0% | 0.00% | 0.0% |
Q2 2021 | $1,213,000 | +273.2% | 145,562 | +144.6% | 0.00% | – |
Q1 2021 | $325,000 | +345.2% | 59,504 | +250.4% | 0.00% | – |
Q4 2020 | $73,000 | -53.5% | 16,984 | -67.4% | 0.00% | – |
Q3 2020 | $157,000 | +4.0% | 52,116 | +6.7% | 0.00% | – |
Q2 2020 | $151,000 | -87.2% | 48,826 | -90.9% | 0.00% | -100.0% |
Q1 2020 | $1,183,000 | -23.9% | 535,226 | +5.0% | 0.00% | +50.0% |
Q4 2019 | $1,554,000 | -21.7% | 509,518 | -21.0% | 0.00% | -33.3% |
Q3 2019 | $1,984,000 | -7.1% | 645,331 | -39.5% | 0.00% | 0.0% |
Q2 2019 | $2,135,000 | +559.0% | 1,067,337 | +1318.7% | 0.00% | – |
Q1 2019 | $324,000 | +468.4% | 75,235 | +316.3% | 0.00% | – |
Q4 2018 | $57,000 | -90.9% | 18,074 | -84.9% | 0.00% | -100.0% |
Q3 2018 | $627,000 | +94.1% | 119,425 | +97.9% | 0.00% | – |
Q2 2018 | $323,000 | -71.4% | 60,353 | -73.3% | 0.00% | -100.0% |
Q1 2018 | $1,128,000 | +1488.7% | 225,619 | +951.3% | 0.00% | – |
Q4 2017 | $71,000 | -65.0% | 21,461 | -60.4% | 0.00% | – |
Q3 2017 | $203,000 | +372.1% | 54,228 | +229.8% | 0.00% | – |
Q1 2017 | $43,000 | -51.1% | 16,443 | -43.2% | 0.00% | – |
Q4 2016 | $88,000 | -29.6% | 28,967 | -37.2% | 0.00% | – |
Q3 2016 | $125,000 | -78.3% | 46,103 | -77.2% | 0.00% | -100.0% |
Q2 2016 | $577,000 | +1054.0% | 201,905 | +1117.5% | 0.00% | – |
Q1 2016 | $50,000 | +22.0% | 16,584 | +41.3% | 0.00% | – |
Q4 2015 | $41,000 | -69.6% | 11,736 | -49.4% | 0.00% | – |
Q1 2015 | $135,000 | -21.1% | 23,199 | -22.9% | 0.00% | – |
Q4 2014 | $171,000 | +30.5% | 30,099 | -6.1% | 0.00% | – |
Q3 2014 | $131,000 | -29.2% | 32,068 | -21.2% | 0.00% | -100.0% |
Q2 2014 | $185,000 | +203.3% | 40,714 | +214.8% | 0.00% | – |
Q4 2013 | $61,000 | -53.4% | 12,935 | -48.1% | 0.00% | – |
Q3 2013 | $131,000 | – | 24,934 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |